Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-05-29
1993-06-08
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544331, 546122, 546123, A61K 31435, C07D47104
Patent
active
052179761
ABSTRACT:
The invention concerns pharmaceutically useful compounds of the formula I, in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, Ra, Rb, A, X and Z have the various meanings defined herein, and their non-toxic salts, and pharmaceutical compositions containing them. The novel compounds are of value in treating conditions such as hypertension and congestive heart failure. The invention further concerns processes for the manufacture of the novel compounds and the use of the compounds in medical treatment.
REFERENCES:
patent: 4920131 (1990-04-01), Huang et al.
patent: 5028615 (1991-06-01), Huang et al.
patent: 5126344 (1992-06-01), Roberts et al.
patent: 5130318 (1992-07-01), Roberts et al.
G. R. Proctor, et al., "Azabenzocycloheptenones. Part XIV. Cyclisation of Amino-acid Derivatives to Tetrahydro-1-benzazepin-5-ones and Tetrahydroquiolin-4-ones" J. Chem. Soc., Perkin Trans. I (1972), 1803-8.
R. D. Youssefyeh, et al. (principal author Huang) J. Med. Chem. (1990), 33, 1186-1194; Chem. Abstr. (1990), 112, 17, abstract 131,890u.
F-C. Huang J. Med. Chem. (1990), 33, 1194-1200.
Gibson Keith H.
Masek Brian B.
Pearce Robert J.
Ratcliffe Arnold H.
Wood Robin
Dentz Bernard
Imperial Chemical Industries plc
Jackson Thomas E.
LandOfFree
1,6-naphthyridone derivatives having angiotensin II antagonist a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,6-naphthyridone derivatives having angiotensin II antagonist a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,6-naphthyridone derivatives having angiotensin II antagonist a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1934258